Fda Pfizer Rsv Vaccine
RSV Vaccine Breakthrough: FDA Approves First-Ever RSV Vaccine for Pregnant Individuals What is RSV? Respiratory syncytial virus (RSV) is a common respiratory virus that can cause severe respiratory illness. It is the leading cause of bronchiolitis and pneumonia in children under 1 year old. Pfizer's RSV Vaccine Receives FDA Approval On March 2, 2022, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to Pfizer's RSV vaccine candidate. Key Points: * Pfizer is the only company with a regulatory application for an RSV vaccine for both adults and infants. * The vaccine is intended for active immunization of pregnant individuals at 32 through 36 weeks gestational age. * The vaccine is designed to protect infants from RSV infection during their first few months of life. How Does the Vaccine Work? The RSV vaccine is a passive immunization vaccine. It works by introducing antibodies against RSV into the body. These antibodies help prote...